Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-018 - Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Impact of Local Therapy in Patients with Oligoprogression
Author(s): Cole Friedes- Abstract
Loading... -
+
EP08.01-063 - Chemoimmunotherapy versus Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer with a PD-L1 Score of 50-100%
Author(s): Mohsin Shah- Abstract
Loading...
-
+
MA05 - Immune Landscape and Molecular Profiling of Lung Cancer
- Type: Mini Oral
- Track: Tumor Biology and Biomarkers
- Presentations: 13
- Moderators:Luis Paz-Ares
- Coordinates: 8/07/2022, 15:45 - 16:45, Hall C8
-
+
MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
16:17 - 16:22 | Author(s): Jennifer A. Marks
- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 12
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.15-07 - Phase II Study of Pembrolizumab and Itacitinib for First Line Treatment of Metastatic NSCLC Expressing PD-L1
Author(s): Melina Elpi Marmarelis- Abstract
Loading...
-
+
MA07 - Overcoming Resistance to EGFR Inhibitors
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 13
- Moderators:Dana Lucia Stanculeanu
- Coordinates: 8/08/2022, 12:15 - 13:15, Hall C7
-
+
MA07.04 - Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
12:22 - 12:27 | Author(s): Melina Elpi Marmarelis
- Abstract
Loading...